Trial record 1 of 62 for:    Estrogen for Triple Negative Breast Cancer
Previous Study | Return to List | Next Study

Estrogen for Triple Negative Breast Cancer

This study has been terminated.
(did not meet efficacy goals after interim analysis)
Sponsor:
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT01083641
First received: March 8, 2010
Last updated: April 4, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2014
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)